Signet Gets FDA IND Approval For Targeted Diffuse Gastric Cancer Therapy
01 Jul 2024 //
BUSINESSWIRE
LAXAI Receives Investment from SIGNET Healthcare Partners
23 Oct 2022 //
BUSINESSWIRE
Signet Healthcare Partners Completes Growth Equity Investment in Juno Pharma
24 Feb 2022 //
BUSINESSWIRE
Signet Therapeutics gets a $10M top-up for next-gen cancer bets
30 Oct 2021 //
BUSINESSWIRE